Use of third-generation cephalosporins for treatment of neonatal infections.
D001424:Bacterial Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000378:metabolism / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007231:Infant, Newborn
D002511:Cephalosporins; D002439:Cefotaxime